業績

• 2026年
• 2025年
• 2024年
• 2023年
• 2022年
• 2021年
• 2020年
• 2019年
• 2018年
• 2017年
• 2016年
• 2015年
• 2014年
• 2013年
• 2012年
• 2011年
• 2010年
• 2009年
• 2008年
• 2007年
• 2006年

2025年

• 原著
• 症例報告
• 総説
• その他

原著

• Yamada S, Arase H, Shojima M, Ago T, Nakano T.

  Comparative validation of serum creatinine- and cystatin C-based surrogate markers for skeletal muscle mass in patients with non-dialysis chronic kidney disease.

  Ren Replace Ther 2025;11:63

• Kitamura H, Tanaka S, Hiyamuta H, Tsuruya K, Kitazono T, Nakano T.

  Associations of Causes of Chronic Kidney Disease with Disease Progression and Mortality: Insights from the Fukuoka Kidney Disease Registry Study.

  Am J Nephrol. 2025;56(3):366-376.

• Suenaga T, Tanaka S, Kitamura H, Tsuruya K, Nakano T, Kitazono T.

  Estimated potassium intake and the progression of chronic kidney disease.

  Nephrol Dial Transplant. 2025 Jun 30;40(7):1362-1373.

• Tanaka S, Okamura K, Tanaka S, Kitamura H, Suenaga T, Tsuruya K, Kitazono T, Nakano T; Fukuoka Kidney Disease Registry (FKR) Study Collaboration Group.

  Associations between Multimorbidity and the Risks of Cardiovascular Disease Events and All-Cause Mortality in Patients with Chronic Kidney Disease.

  Am J Nephrol. 2025;56(5):605-617.

• Matsukuma Y, Tanaka S, Nakayama M, Kitamura H, Tsuruya K, Kitazono T, Nakano T.

  Association between the urinary sodium-to-potassium ratio and apparent treatment-resistant hypertension in Japanese patients with non-dialysis dependent chronic kidney disease: the Fukuoka Kidney disease Registry study.

  Hypertens Res. 2025 Aug;48(8):2163-2172.

• Nakano T, Kitamura H, Tsuneyoshi S, Tsuchimoto A, Torisu K, Tsujikawa H, Kawanishi H, Tsuruya K, Kitazono T.

  Predictors of encapsulated peritoneal sclerosis in patients undergoing peritoneal dialysis using neutral-pH dialysate.

  Clin Exp Nephrol 2025;29(2):212-220.

症例報告

• Uehara K, Yamada S, Mizuuchi Y, Kitazono T, Nakano T.

  Multiple relapses of sigmoid volvulus in a patient on automated peritoneal dialysis: the role of an elongated sigmoid colon and peritoneal dialysis as potential predisposing factors.

  CEN Case Rep. 2025 Aug;14(4):507-508.

• Yoshida Y, Ueki K, Matsukuma Y, Tsuchimoto A, Ataka E, Okamoto H, Torisu K, Hara Y, Ikeda H, Kitazono T, Nakano T.

  A case of neuron-derived neurotrophic factor-positive, syphilis-related membranous nephropathy that achieved spontaneous remission.

  CEN Case Rep. 2025 Jun;14(3):318-323.

• Ueki K, Tsuchimoto A, Matsukuma Y, Kitazono T, Nakano T.

  A case of end-stage kidney disease due to Alport syndrome diagnosed by skin biopsy after review of a renal biopsy 12 years ago.

  CEN Case Rep 2025;14(1):111-112.

総説

• Tsuchimoto A, Matsukuma Y, Ueki K, Masutani K, Nakano T.

  Telepathology in Renal Allograft Pathology: Current Trends and Future Prospects.

  Nephron. 2025;149(Suppl. 1):52-59.

その他

• Yamada S, Nakano T.

  Glomerular filtration of creatinine: expanding its clinical utility as a skeletal muscle mass index in non-dialysis CKD patients.

  Clin Exp Nephrol. 2025 Jun;29(6):872-874.

• Yamada S, Arase H, Kitazono T, Nakano T.

  Letter to the editor: Novel equations incorporating the sarcopenic index based on serum creatinine and cystatin C to predict appendicular skeletal muscle mass in patients with nondialysis CKD.

  Clin Nutr. 2024 Dec;43(12):73-74.